Smart-Money SignalDistribution · 36/100— Insiders are net sellers over 90 days (-$18.9M, 17 sales vs 8 buys)
Revenue$4.0B
Net Income$369.0M
EPS$0.31
Gross Margin49.5%
Market Cap$38.1B
Price Performance
Historical data including institutional events
Company Profile
R
Richard Francis
CEO & Executive Director
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
